HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 202 filers reported holding HEALTH CATALYST INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,778 | -97.5% | 1,065 | -96.9% | 0.00% | – |
Q2 2023 | $431,776 | +2329.4% | 34,542 | +2168.0% | 0.00% | – |
Q1 2023 | $17,773 | +0.6% | 1,523 | -8.4% | 0.00% | – |
Q4 2022 | $17,667 | -36.9% | 1,662 | -41.9% | 0.00% | – |
Q3 2022 | $28,000 | -72.0% | 2,862 | -58.5% | 0.00% | – |
Q2 2022 | $100,000 | -89.4% | 6,899 | -80.9% | 0.00% | -100.0% |
Q1 2022 | $943,000 | +57.7% | 36,071 | +138.9% | 0.00% | – |
Q4 2021 | $598,000 | +60.8% | 15,098 | +102.8% | 0.00% | – |
Q3 2021 | $372,000 | -87.0% | 7,446 | -85.6% | 0.00% | -100.0% |
Q2 2021 | $2,870,000 | +1443.0% | 51,702 | +1196.8% | 0.00% | – |
Q1 2021 | $186,000 | -38.2% | 3,987 | -42.4% | 0.00% | – |
Q4 2020 | $301,000 | +356.1% | 6,919 | +284.2% | 0.00% | – |
Q3 2020 | $66,000 | -67.6% | 1,801 | -74.3% | 0.00% | – |
Q2 2020 | $204,000 | +32.5% | 7,010 | +18.9% | 0.00% | – |
Q1 2020 | $154,000 | +120.0% | 5,897 | +192.7% | 0.00% | – |
Q4 2019 | $70,000 | +536.4% | 2,015 | +438.8% | 0.00% | – |
Q3 2019 | $11,000 | – | 374 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Norwest Venture Partners XI, LP | 876,045 | $32,063,000 | 100.00% |
Norwest Venture Partners XII, LP | 876,045 | $32,063,000 | 69.68% |
Nepsis Inc. | 197,178 | $7,217,000 | 3.46% |
Karani Asset Management LLC | 133,968 | $4,903,000 | 3.29% |
ADAMS STREET PARTNERS LLC | 201,548 | $6,639,000 | 1.75% |
HHR Asset Management, LLC | 412,423 | $15,095,000 | 1.50% |
Mesirow Financial Investment Management, Inc. | 9,510 | $348,000 | 1.49% |
ASHFORD CAPITAL MANAGEMENT INC | 342,500 | $12,536,000 | 1.49% |
Roubaix Capital, LLC | 31,889 | $1,167,000 | 1.38% |
Monarch Partners Asset Management LLC | 154,847 | $5,667,000 | 1.28% |